Activity of clinafloxacin against multidrug-resistant Enterococcus faecium.
AUTOR(ES)
Burney, S
RESUMO
Enterococci resistant to ampicillin, vancomycin, and/or aminoglycosides are a growing clinical problem. We studied the in vitro activity of the new fluoroquinolone clinafloxacin (PD 127,391) against 15 clinical isolates of multidrug-resistant Enterococcus faecium. In kill-kinetic studies, clinafloxacin (1 microgram/ml) was bactericidal against 7 of 12 susceptible isolates, although substantial regrowth occurred in 4 isolates at 48 h. The addition of ampicillin (20 micrograms/ml) resulted in bactericidal activity in all 12 isolates, and no regrowth was seen. For three isolates resistant to clinafloxacin, effective killing was not observed at these concentrations of antibiotics. Clinafloxacin with ampicillin shows promising activity against many of these multiply resistant enterococci.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284614Documentos Relacionados
- Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
- Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.
- In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa
- Multidrug-resistant tuberculosis
- Trends in multidrug-resistant tuberculosis